8 completed, 3 terminated, 3 unknown, 3 withdrawn. 4 Phase 3, 3 Phase 2, 2 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Withdrawn 2 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Not applicable | 2 | Terminated 1, Unknown 1 |
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Obstetrix Medical Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of MHP 3.0 in Two Clinical Settings MHP - Telemedicine | Not applicable | Unknown | Naima Health LLC | 150 | 2022-06-20 | 2022-08-12 |
| Vaginal Pessary Versus Expectant Management for Placenta Previa Cervical Pessary Placement - Placenta Previa | Not applicable | Terminated | Pediatrix | 17 | 2016-10-01 | 2018-09-27 |
| Non-Invasive Screening for Fetal Aneuploidy Maternal Blood Draw - Down Syndrome, Edwards Syndrome | Unknown | Progenity, Inc. | 340 | 2015-03-01 | 2018-08-28 | |
| Vaginal Progesterone in Twins With Short Cervix Vaginal Progesterone gel., fetal fibronectin swab., Placebo gel - Premature Birth | Phase 2 / Phase 3 | Withdrawn | Obstetrix Medical Group | 2014-03-01 | 2014-12-19 | |
| National Prevalence and Impact of Noninvasive Prenatal Testing non-invasive prenatal testing - Aneuploidy | Completed | Obstetrix Medical Group | 4488 | 2014-01-01 | 2019-06-19 | |
| Optimal Management of Vasa Previa Study - A Retrospective Study Vasa Previa | Completed | Obstetrix Medical Group | 68 | 2014-01-01 | 2019-01-11 | |
| Neonatal Outcome by Reason for Delivery Preterm Delivery | Completed | Obstetrix Medical Group | 995 | 2013-07-01 | 2019-06-18 | |
| Maternal Uterine Artery Doppler Study Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly. - Maternal-Fetal Exchange | Completed | Obstetrix Medical Group | 52 | 2012-09-01 | 2016-11-22 | |
| Cerclage for Prevention on Preterm Birth in Women With Placenta Previa Placement of a Cervical Cerclage, Standard Expectant Management - Premature Birth, Placenta Previa | Phase 3 | Withdrawn | Obstetrix Medical Group | 2012-03-01 | 2014-12-19 | |
| Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM) 17-alpha-hydroxy-progesterone caproate, Makena®, Castor Oil (Placebo) - Preterm Delivery | Phase 2 / Phase 3 | Completed | Obstetrix Medical Group | 152 | 2011-10-01 | 2018-06-28 |
| Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes Intra-amniotic Infection | Unknown | ProteoGenix, Inc. | 900 | 2008-06-01 | 2010-07-21 | |
| Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes Intra-amniotic Infection, Preterm Birth | Completed | ProteoGenix, Inc. | 79 | 2008-06-01 | 2010-07-21 | |
| Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR Tandem MS test for inborn errors of metabolism - Hydrops Fetalis, Fetal Growth Retardation | Terminated | Obstetrix Medical Group | 48 | 2006-03-01 | 2014-12-19 | |
| fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo Fetal Fibronectin, Salivary Estriol - Preterm Delivery, Preterm Birth | Withdrawn | Obstetrix Medical Group | 2005-08-01 | 2014-12-19 | ||
| Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM) Retention of Cerclage, Removal of Cerclage, Removal vs. Retention of Cervical Cerclage - Fetal Membranes, Premature Rupture | Phase 4 | Terminated | Obstetrix Medical Group | 58 | 2004-11-01 | 2014-12-19 |
| 17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies 17-alpha-hydroxyprogesterone caproate injectable, Placebo - Preterm Birth | Phase 2 / Phase 3 | Completed | Obstetrix Medical Group | 321 | 2004-11-01 | 2016-04-11 |
| A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome Betamethasone or Dexamethasone (2nd course of ACS), Placebo - Preterm Delivery | Phase 4 | Completed | Obstetrix Medical Group | 437 | 2003-11-01 | 2015-01-07 |
Premature Birth (10) · Down Syndrome (2) · Obstetric Labor, Premature (2) · Placenta Previa (2) · Preterm Premature Rupture of the Membranes (2) · Aneuploidy (1) · Fetal Growth Retardation (1) · Fetal Membranes, Premature Rupture (1) · Hydrops Fetalis (1) · Trisomy 18 Syndrome (1) · Vasa Previa (1)
Saline Solution (2) · 17 alpha-Hydroxyprogesterone Caproate (1) · Betamethasone (1) · Castor Oil (1) · Cerclage, Cervical (1) · Dexamethasone (1) · Fibronectins (1) · Pregnancy (1) · Progesterone (1) · Progestins (1) · Watchful Waiting (1) · dichlorobis(azomycin)platinum II (1)
United States (16)
Kimberly Maurel, RN, MSN, CNS (4) · Thomas Garite, MD (4) · Andrew Combs, MD (3) · Irene Stafford, MD (2) · Andrew Combs, MD, PhD (1) · Karrie Francois, MD (1) · Kimberly Maurel, MSN (1) · Richard Lee (1) · Richard Porecco, MD (1) · Richard Porreco, MD (1) · Thomas H Strong, MD (1)